Walgreens Boots Alliance, a global pharmacy-led, health and wellbeing enterprise, and McKesson, agreed to form a joint venture in Germany. Walgreen will hold 70% and McKesson 30%. Financial terms were not disclosed. “We are excited to join forces with Walgreens Boots Alliance, and through this strategic partnership we are securing the future of pharmaceutical distribution in the German market. This transaction provides a unique opportunity to drive operational success in a complex environment,” Kevin Kettler, McKesson Chairman of Europe’s Management Board.